BRANDON GUINVARCH: Open Payments
NPI 1902538101 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,188 in 64 payments from 13 companies in 2025. Trend: 2023 $1,708 · 2024 $1,169 · 2025 $1,188
Food & beverage: $1,188
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $258 |
| PFIZER INC. | 11 | $194 |
| Amgen Inc. | 16 | $146 |
| AstraZeneca Pharmaceuticals LP | 8 | $145 |
| Lilly USA, LLC | 4 | $86 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| Dexcom, Inc. | 3 | $70 |
| SANOFI-AVENTIS U.S. LLC | 2 | $67 |
| ABBVIE INC. | 2 | $50 |
| Exact Sciences Corporation | 1 | $33 |
Products named: NURTEC ODT, Ozempic, Wegovy, AIRSUPRA, TRELEGY ELLIPTA, OTEZLA, Dexcom G6 Transmitter, TZIELD.
Industry payments across CA — which companies pay providers there.
